Sales & Marketing Bad KOL data is expensive: Harnessing high-quality data for ... As biopharmas increasingly rely on AI and advanced data-driven technologies, evaluating the quality of data is critical.
Market Access The outlook for healthtech and life sciences in 2025 2024 was pivotal for UK Life Sciences’ venture funding landscape.
Market Access True innovation in life sciences is only possible through a ... Many of the biggest life sciences breakthroughs are the result of European research.
Events Partner Content Innovative Strategies for Patient Centered Clinical Research At the Innovative Strategies for Patient Centered Clinical Research Conference, July 11-12, 2018 in Boston, MA will bring together the foremost leaders in Clinical Innovation, Clin
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.